Navigation Links
IPS Appoints Dave Wareheim as Bioprocess Subject Matter Expert
Date:1/20/2010

Integrated Project Services (IPS), a leading, full-service engineering, construction, commissioning and qualification company dedicated to assisting life science companies execute technically complex projects, today announced the appointment of Dave Wareheim as Bioprocess Subject Matter Expert.

Lafayette Hill, PA (Vocus) January 20, 2010 -- Integrated Project Services (IPS), a leading, full-service engineering, construction, commissioning and qualification company dedicated to assisting life science companies execute technically complex projects, today announced the appointment of Dave Wareheim as Bioprocess Subject Matter Expert. In this role, Mr. Wareheim will leverage his extensive industry insight and knowledge of operations, simulation and throughput analysis, process development, process engineering, process architecture and overall process consultancy.

"Dave brings an in-depth knowledge of cell culture processes and the design/implementation of Single-Use (SU) technologies; this knowledge will significantly improve operational capabilities, throughput and process control for our pre-clinical, clinical and commercial manufacturing customers,” said Dave Goswami, P.E., President and Chief Operating Officer, IPS. “His combined experience in large biotech projects and SU systems is unmatched in the architectural/ engineering (A/E) side of the business. Dave joining the IPS team really balances our existing strengths in process architecture, equipment and execution of process projects with knowledge of cell culture science and operations, enhancing IPS’ position as a top tier provider of bioprocess engineering services.”

Mr. Wareheim brings over thirty years of experience as a bioprocess subject matter expert for global small and large scale Research & Development (R&D) and commercial manufacturing projects. For the last 8 years, he was with Centocor-Ortho Biotech as Master Engineering Fellow and was responsible for the process implementation of SU biotechnologies in both upstream and downstream operations. He led an effort to streamline downstream processing that ultimately led to patent submission and design/build of a first ever system. Previously, Mr. Wareheim worked as a Senior Process Engineering Specialist where he provided process consulting on the design, implementation and qualification of bioreactors, automated UF/DF, and other biotechnology operations. At SmithKline Beecham, Mr. Wareheim was a Computer Process Systems Manager responsible for the design, implementation and qualification of bioreactors, equipment and downstream units. He began his career as a Staff Scientist with the Frederick Cancer Research Center (FCRC) where he designed and executed bench scale isolation of anti-tumor anti-neoplastics.

Mr. Wareheim earned a Bachelor of Science degree in Biology from Towson State University. Considered an expert in disposable technology and fermentation, he has presented at numerous meetings and conferences and has written numerous technical manuscripts and book chapters.

About IPS
Integrated Project Services (IPS), www.ipsdb.com, is a full-service engineering firm dedicated to helping clients succeed with capital projects and improve operations. We specialize in complex facilities in high-tech and highly regulated industries providing technical consulting, engineering, construction and commissioning and qualification. For over twenty years, we have applied LEAN techniques throughout the project life cycle, continually finding ways to do things better and more efficiently, delivering higher quality and controlling costs. Headquartered in Lafayette Hill, PA, IPS has branch offices in North Carolina, New Jersey, California, Indiana and India.

CONTACT:
Kate McCorriston
610.828.4090 ext. 1217

# # #

Read the full story at http://www.prweb.com/releases/IPS/Dave_Wareheim/prweb3467294.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Tunnell Consulting, Inc. announced that Frédéric Lefebvre ... will focus on acquiring new accounts and work closely with existing Tunnell clients throughout ... brings to our European clients more than 15 years of experience in the pharmaceutical ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... years and Open Access publishing is one of the popular publication models that ... open access journals and 3000+ International Conferences across the globe, ...
(Date:2/9/2016)... , Feb. 9, 2016  DNAtrix, a ... for cancer, announced that its lead product, ... Commission as an orphan medicinal product for ... form of glioma, strikes approximately 25,000 people ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> ...
(Date:2/9/2016)... , February 9, 2016 Web ... paper and protect IP   E-WorkBook 10 ... rolled out in Germany early this ... valuable IP. Users will be able to search for information ... as part of the application, to boost collaboration and productivity. ...
Breaking Biology Technology:
(Date:2/2/2016)... Checkpoint Inhibitors for Cancer – Explore ... you interested in the future of cancer drugs? ... Visiongain,s report gives those predictions to 2026 at ... Avoid falling behind in data or losing ... those emerging cancer therapies can achieve. There you ...
(Date:2/2/2016)...   Parabon NanoLabs (Parabon) announced today ... Office and the Defense Forensics and Biometrics Agency ... company,s Snapshot Kinship Inference software for ... defense-related DNA forensics.  Although Snapshot is best known ... ancestry from DNA evidence), it also has the ...
(Date:2/1/2016)... 1, 2016 Rising sales of ... global touchfree intuitive gesture control market size ... sales of consumer electronics coupled with new technological advancements ... size through 2020   --> ... new technological advancements to drive global touchfree intuitive gesture ...
Breaking Biology News(10 mins):